http://www.dowjonesmonitor.com/
by Dan Kolber
Post No. 3,119 The following is brought to you by Intellivest Securities Research, Inc. Toward the end of this Blog is a list of the Dow 30 current CEOs, and a recent ranking of the Dow 30 components by market capitalization and a summary of recent Dow 30 components' SEC filings.
A read of the print editions of Thursday's Wall Street Journal, Financial Times, Investor's Business Daily, New York Times, USA Today, Atlanta Journal & Constitution & Daily Report (Ga. - carries Bloomberg) yielded the following stories about Dow Jones Industrial Average 30 component companies and the Dow with stories about the Dow aggregated first and then items about Dow Jones Industrial Average 30 companies presented alphabetically, followed by a separate table of Dow component's symbol and Wednesday's closing stock prices and related data in alphabetical order.
The Dow Jones Industrial Average: The Dow Jones Industrial Average closed Wednesday at 17698.18 down 77.94 or 0.44% from Tuesday's close of 17776.12. For the year the Dow is down 0.70% Of the Dow components 8 gained and 22 declined. The biggest gainer dollar-wise and percentage-wise was Goldman Sachs up $4.26 or 2.27%. The biggest decliner dollar-wise was 3M down $2.43 and percentage-wise was Walmart down 1.87%.
WSJ pC4 "Stocks decline on growth worries" by Saumya Vaishampayan says stocks kicked off the 2nd quarter with a loss after weak economic data added to concerns about slowing US growth & corp. profit.
IBD pB3 "Distribution count rises, yet indexes shave losses" by David Saito-Chung says Wednesday's action saw moderate losses in higher volume while the current outlook is uptrend under pressure.
NYT pB6 "Worries on earnings send shares down for a 2nd day" & AJC pA15 "Stocks dip amid new reports" by AP says discouraging economic news caused concerns about corp earnings sending prices down Wed for the 2nd day in a row. US construction spending fell in Feb.
As of the open of the market on Thursday the current divisor for the Dow Jones Industrial Average found at page C5 of Wednesday's Wall St. Journal is 0.14985889030177. Thursday's trailing P/E ratio is 16.16 down from yesterday's trailing P/E ratio of 16.23 (last year it was 16.30). Today's P/E estimate is 16.07 down from Wednesday's P/E estimate of 16.30 (year ago it was 14.74) and today's dividend yield is 2.31 up from yesterday's dividend yield of 2.28 (last year it was 2.15). The Dow's all-time high was 18288.63 on March 2, 2015. The 12 year low close for the Dow was on March 9, 2009 when it fell to 6,547.05.
Wednesday's Dow Jones Industrial Average numerator is 2652.23 down 11.69 from Tuesday's average numerator of 2663.91. This is the sum of all 30 closing prices. A short cut to the Dow numerator is to multiply the closing Dow by the Divisor. Now, if you divide the Dow numerator change for today by the divisor (0.14985889030177) you get the change in today's Dow. A dollar increase or decrease in a Dow stock results in a $6.67 change in the Dow Index.
The average closing price (the closing numerator divided by 30) of Wednesday's Dow Jones Industrial Average was $88.41 down 39 cents from Tuesday's closing average of $88.80. The median closing price of Wednesday's Dow Jones Industrial Average was $83.39 (PG/XOM) down 23 cents from Tuesday's median closing price of $83.62 (WMT/XOM). The lowest volume was Travelers and the highest volume was Apple.
If Wednesday morning before the market opened you had purchased 100 shares of each of the Dow Jones Industrial Average 30 shares (assuming you could buy fractional shares and assuming no transaction costs or dividends) and sold at the close you would have lost $1,169 ($266,391- $265,223).
4/1//15 Wed. 4:43 pm MarketWatch by Anora Mahmudova & Sara Sjolin says April Fools’ Day, indeed. U.S. stocks kicked off the month, and the start of the second quarter, on a sour note, with the main benchmarks ending Wednesday’s session with modest losses as a batch of weaker-than-expected economic reports further eroded confidence.Futures were already pointing to weakness earlier in the session as Asian markets tumbled, U.S. stocks turned lower after private-sector job gains came in weaker than expected. A larger-than-forecast drop in ISM manufacturing index also suggested the U.S. economy is weakening.Jeffrey Saut, chief investment strategist at Raymond James, noted that the stock market hasn't felt confident about the economy since November.
“At the moments there are too many indicators that seem to point to being patient and wait until fundamentals improve. There is internal deterioration, softening economy and falling earnings expectations. It is difficult to be patient, but that’s exactly what investors should be,” Saut said.
Patience was certainly not on display as the S&P 500 SPX, -0.40% closed 8.20 points, or 0.4%, lower at 2,059.69. The benchmark index closed below a key technical level, with some analysts suggesting the index is vulnerable to further declines.The Dow Jones Industrial Average DJIA, -0.44% dropped as much as 190 points in early trade, but recovered some of the losses to end the session 77.94 points, or 0.4%, lower at 17,698.18. More than two-thirds of the 30 components on the average closed lower.The Nasdaq Composite COMP, -0.42% ended the session down 20.66 points, or 0.4%, to 4,880.23. While equities markets pushed through several record milestones in the first quarter, are low interest rates (plus a possible U.S. rate hike) and low oil prices likely to keep the party going on Wall Street and overseas? Randy Frederick, managing director of trading and derivatives at the Schwab Center for Financial Research, noted that the market has been extremely difficult to predict.“Looking at our open put/call ratios and Vix, those indicators are neither bullish, nor bearish, as they are not at extreme levels,” Frederick said, adding that long investors may need to tune out the short-term noise of stock fluctuations U.S. stocks fell Tuesday, pulling back after two sessions of gains and putting the Dow Jones Industrial Average on track for a decline in the first quarter. Charter Communications agreed to acquire Bright House Networks for $10.4 billion.
Data: Private-sector employment gains continued in March but at a slower pace than in the prior month. Employers added 189,000 jobs last month, Automatic Data Processing Inc. reported Wednesday. Separately, U.S. manufacturers grew at the slowest pace in March in almost two years and employment levels also weakened, according to the The Institute for Supply Management’s survey. Outlays for U.S. construction projects decreased 0.1% in February to a seasonally adjusted annual rate of $967.2 billion.Stocks to watch: Shares of GoDaddy Inc. GDDY, -0.57% jumped 31% in its IPO debut.Shares of major airline companies took a hit after downgrades by Deutsche Bank.Delta Air Lines DAL, +0.07% and American Airlines Group AAL, +0.24% fell 3.8% and 4.4% respectively.Sarepta Therapeutics Inc. SRPT, +0.14% shares rallied 7.6% after the biotech firm appointed Edward Kaye as interim CEO with immediate effect and said it is pushing ahead with regulatory and clinical work needed to gain approval for its lead product candidate. Other markets: U.S. Treasuries rallied today, sending the yield on the 10-year note down seven basis points to 1.87%, following weak ADP and ISM data. Oil CLK5, -1.24% settled with biggest gain in two months, gaining $2.49 or 5.2% to $50.09 a barrel. Gold GCM5, -0.36% bounced back after two days of losses to settle 2.1% higher at $1,208.20. European stocks finished with modest gains, with the benchmark STOXX SXXP, +0.31% gaining 0.3%. Asian stock markets closed mixed, with China’s benchmark Shanghai Composite Index SHCOMP, +1.66% ending above 3,800 for the first time since 2008.
Thursday's Dow News followed by Wednesday's Closing Dow Numbers:
American Express: No mentions found.
Apple: IBD pA4 "For many, smartphone is way to web" by Reinhardt Krause says the popularity of mobile devices such as Apple's iPhone is changing the broadband market as now 10% of Americans own a smartphone but don't have broadband at home.
Boeing: IBD pA2 "Boeing lag seen not hurting Q1" says Boeing may have only delivered 177 jet lower than its estimate for 180 so Sterne Agee lowered its 1Q earnings estimate for Boeing by a dime to $1.80 a share.
Caterpillar: No mentions found.
Chevron: No mentions found.
Cisco: No mentions found.
Coke: No mentions found.
Disney: No mentions found.
DuPont: No mentions found.
Exxon: No mentions found.
GE: No mentions found.
Goldman Sachs: WSJ pC2 "Request to delay trial of ex-staffer denied" by Samuel Rubenfeld, NYT pB5 "New stumble in trial of former Goldman programmer" by Ben Protess say a NY judge rejected a request by the gov to delay the trial for a Former GS programmer charged with theft of computer code.,
Home Depot: No mentions found.
Intel: No mentions found.
IBM: No mentions found.
JPMorgan: WSJ pC2 "Gorman rec3eives 25% raise" by Justin Baer says James Dimon received $20 mil in '14 same as in '13.
Johnson & Johnson: IBD pA2 "Wave of biosimilars set to roil pharma" by Amy Reeves says Pfizer is moving big into biosimilars with its $17 bil purchase of Hospira. Merck is developing a biosimilars version of Sanofi's diabetes drug Lantus and Johnson & Johnson's Remicade is a biosimilars.
McDonald's: WSJ pA1 "McDonald's to raise pay in its stores, joining others" by Annie Gasparro, Eric Mortah, NYT pB1 "McDonald's to raise pay at outlets it operates" by Stephanie Strom, IBD pA2 "McDonald's gives pay raise," AJC pA15 "McDonald's boosts pay for employees", USAT p13 "McDonald's hikes pay for thousands" by Kaja Whitehouse, Paul Davidson say McDonald's on July 1 will pay at least $1 an hour more than the local minimum wage for employees at the 1,500 stores it owns in the US, a 10% raise.
Merck: IBD pA2 "Wave of biosimilars set to roil pharma" by Amy Reeves says Pfizer is moving big into biosimilars with its $17 bil purchase of Hospira. Merck is developing a biosimilars version of Sanofi's diabetes drug Lantus and Johnson & Johnson's Remicade is a biosimilar.
Microsoft: No mentions found.
Nike: No mentions found.
Pfizer: IBD pA2 "Wave of biosimilars set to roil pharma" by Amy Reeves says Pfizer is moving big into biosimilars with its $17 bil purchase of Hospira. Merck is developing a biosimilars version of Sanofi's diabetes drug Lantus and Johnson & Johnson's Remicade is a biosimilars.
Procter & Gamble: NYT pB5 "560,000 acre swath of Florida land going on the market" by David Gelles says the largest unbroken parcel of undeveloped private land east of the Mississippi is going on the market which Procter & Gamble, a former owner" used to harvest its trees to make diapers.
3M: No mentions found.
Travelers: No mentions found.
United Technologies: No mentions found.
UnitedHealth: No mentions found.
Verizon: No mentions found.
Visa: No mentions found.
Walmart: NYT pB1 "Walmart emerges as unlikely social force" by Hiroko Tabuchi, Micahel Barbaro, IBD pA1 "Walmart will cut some prices as b road pay increases begin" by James Detar, AJC pA14 "Why businesses enter religious objection fray" by Michelle Chapman says Walmart urged Ak gov to veto a bill that would allow businesses to discriminate against gays.
Wednesday's Closing Dow Numbers:
| Symbol | Last Sale | Change | % Change | Share Volume | Market |
|---|---|---|---|---|---|
| AXP | ▲ | NYSE | |||
| AAPL | ▼ | NASDAQ-GS | |||
| BA | ▼ | NYSE | |||
| CAT | ▼ | NYSE | |||
| CVX | ▼ | NYSE | |||
| CSCO | ▼ | NASDAQ-GS | |||
| KO | ▲ | NYSE | |||
| DIS | ▲ | NYSE | |||
| DD | ▼ | NYSE | |||
| XOM | ▼ | NYSE | |||
| GE | ▲ | NYSE | |||
| GS | ▲ | NYSE | |||
| HD | ▼ | NYSE | |||
| INTC | ▼ | NASDAQ-GS | |||
| IBM | ▼ | NYSE | |||
| JPM | ▼ | NYSE | |||
| JNJ | ▼ | NYSE | |||
| MCD | ▼ | NYSE | |||
| MRK | ▼ | NYSE | |||
| MSFT | ▲ | NASDAQ-GS | |||
| NKE | ▼ | NYSE | |||
| PFE | ▼ | NYSE | |||
| PG | ▲ | NYSE | |||
| MMM | ▼ | NYSE | |||
| TRV | ▼ | NYSE | |||
| UTX | ▼ | NYSE | |||
| UNH | ▼ | NYSE | |||
| VZ | ▲ | DualListed | |||
| V | ▼ | NYSE | |||
| WMT | ▼ | NYSE |
Here are the current CEOs of the Dow 30 Companies:
AT&T T Randall L. Stephenson (Dallas, TX)
Apple: Tim Cook (Cupertino, CA)
American Express AXP Kenneth I. Chenault (NY, NY)
Boeing BA W. James McNerney, Jr. (Chicago, Ill)
Caterpillar CAT Douglas Oberhelman (Peoria, Ill.)
Chevron CVX John Watson (San Ramon, CA)
Cisco CSCO John Chambers (San Jose, CA)
Coca Cola KO Muhtar Kent (Atlanta, GA)
Disney DIS Robert Iger (Burbank, CA)
DuPont DD Ellen Kullman (Wilmington, DE)
ExxonMobil XOM Rex W. Tillerson (Irving, Tx)
GE Jeffrey R. Immelt (Fairfield, CT)
Goldman Sachs GS Lloyd Blankfein (NY, NY)
Home Depot HD Craig Menear (Atlanta, GA)
Intel INTC Brian M. Krzanich (Santa Clara, CA)
IBM Virginia M. Rometty (Armonk, NY)
JPMorgan Chase JPM Jamie Dimon (NY, NY)
Johnson & Johnson JNJ Alex Gorsky (New Brunswick, NJ)
McDonald's MCD Steve Easterbrook (Oak Brook, Ill)
Merck MRK Kenneth Frazier (Whitehouse Station, N.J.)
Microsoft MSFT Satya Nadella (Redmond, WA)
Nike NKE Mark Parker (Beaverton, OR)
Pfizer PFE Ian Read (NY, NY)
Procter & Gamble PG A. G. Lafley (Cincinnati, OH)
3M MMM Inge Thulin (St. Paul, MN)
Travelers TRV Jay S. Fishman (NY, NY)
UnitedHealth UNC Stephen Hemsley (Minnetonka, MN)
United Technologies UTX Greg Hayes (Hartford, CT)
Verizon VZ Lowell McAdam (NY, NY)
Visa V Charles W. Scharf (San Francisco, CA)
Wal-Mart WMT Doug McMillon (Bentonville, ARK)
***************************
Here are the Dow Jones Industrial Average 30 as of 3/22/15 ranked in order of market capitalization in billions:
1. Apple AAPL $733.34
2. Exxon Mobil XOM $354.62
3. Microsoft MSFT 351.78
4. Johnson & Johnson JNJ 284.72
5. Wal-Mart WMT 268.87
6. GE 255.65
7. JPMorgan Chase JPM 229.36
8. Procter & Gamble PG 228.84
9. Pfizer PFE 209.91
10. Verizon VZ 205.94
11. Chevron CVX 201.24
12. Disney 184.28
13. Coke KO 177.49
14. Merck MRK 166.26
15. IBM 160.99
16. Home Depot HD 153.44
17. Cisco CSCO 145.18
18. Intel INTC 144.28
19. UnitedHealth UNH 113.62
20. Boeing BA 108.83
21. United Technologies UTX 108.37
22. 3M MMM 105.68
23. McDonald' s MCD 93.28
24. Nike NKE 88.10
25. Goldman Sachs GS 87.21
26. American Express AXP 84.29
27. DuPont DD 67.31
28. Caterpillar CAT 49.21
29. Visa V 42.35
30. Travelers TRV 35.26
****************************************
Here are the latest 8K, 10Q & 10K & Proxy & certain other SEC filings as of 3/22/15 for the prior 90 day period:
Symbol & Co. Name/Date of Filing/Form Filed/ Comments
American Express AXP:
3/16/15 8K re: delinq. & write-off stats for 3 mos. thru 2/15/15
3/11/15 8K re: increase of quarterly dividend & repurchase of up to $6.6 of shares
3/2/15 8K re: issuance of preferred shares
2/24/15 10K re: FY ended 12/31/14
2/17/15 8K re: delinq. & write-off states for 3 months thru 1/15
2/12/15 8K re: end of exclusive deal w/Costco
1/21/15 8K re: 4Q & FY '14 earnings
1/15/15 8K re: delinq. & write-off delinq. stats. for 3 mos ended 12/31/14.
Apple AAPL:
3/13/15 8K re: amdmt. to employee stock purchase plan
2/9/15 8K re: issuance of notes
1/28/15 8K re: change to fin'l stmts due to change of reporting
1/28/15 10Q & 1/27/15 8K re: Qtr. ended 12/27/14
1/22/15 2 14A Proxies re: Annual Mtg of Shareholders on 3/10/15 at 9 am at HG at Cupertino, CA
Boeing BA:
3/13/15 14A Def. Proxy re: Annual Shareholders Mtg on 4/27/15 at 9 am at Field Museum, Chicago
2/20/15 8K re: issuance of senior notes
2/12/15 10K & 1/28/15 8K re: FY ended 12/31/14
2/10/15 8K re: retirement of Linda Z. Cook from Board
1/27/15 8K re: 4Qtr fin'l results
Caterpillar CAT:
3/19/15 8K re: sales thru 2/15
2/19/15 8K re: sales thru 1/15
2/17/15 & 1/27/15 8K re: FY ended 12/31/14
1/27/15 8K re: 4Qtr fin'l results
1/26/15 8K re: 3 mos ended 12/31/14 retail sales stats
Chevron CVX:
3/3/15 8K re: issuance of Floating Rate Notes
2/20/15 10K & 1/30 8K re: FY ended 12/31/14
2/3/15 8K re: election of Jeanette L. Ourada, Corp. VP & Comptroller
1/30/15 8K re: 4Qtr fin'l results
Cisco CSCO:
3/19/15 8K re: exec pre-arranged stock trading plan
2/18/15 & 2/11/15 8K re: 2Qtr ended 1/24/15
Coke KO:
3/2/15 Def. 14A Proxy re: Annual Mtg of Shareholders 11 am, Cobb Galeria Centre, Atlanta
3/10/15 & 3/3/15 8Ks re: issuance of Floating Rate Notes
2/25/15 10K & 2/10/15 8K re: FY ended 12/31/14
2/20/15 8K re: retirement from Board of James D. Robinson & Peter V. Ueberroth
2/18/15 8K re: Amdmt to employee stock option plans
Disney DIS:
3/13/15 8K re: voting results of 3/12 Annual Shareholders Mtg
2/11/15 Def14A re: shareholder proposals
2/5/15 8K re: Agreement for COO Thomas O. Stagg
2/3/15 10Q & 2/3/15 8K re: Qtr ended 12/27/14
1/16/15 Def. 14A Proxy re: Annual Mtg. of Shareholders at 10 am 3/12/15 at Palace of Fine Arts, SF
DuPont DD:
3/17/15 - 3/19/15 Def. Proxy 14A re: Trian's proposal to add Directors
2/5/15 8K re: election to Board of Edward D. Breent & James L. Gallogly
2/5/15 10K & 1/27/15 8K re: FY ended 12/31/14
1/27/15, 1/15/15, 1/14/15, 1/13/15, 1/9/15 (five) 14A Proxy: re: Nelson Peltz's Trian's proposal to break-up DuPont
1/12/15 8K re: 4Qtr fin'l results
ExxonMobil XOM:
3/10/15 8K re: 3/4/15 analyst meeting
3/6/15 8K re: issuance of Floating rate Notes
2/25/15 10K & 2/24/15 8K & 2/2/15 8K re: 10K for FY ended 12/31/14
GE:
3/10/15 def. 14A Proxy re: Shareholder Mtg 4/22/15 10am at Cox Conv. Ctr. Oklahoma City
2/27/15 10K re: FY ended 12/31/14
2/11/15 8K re: Amdmt By-laws re: proxy access by 3% holders
1/23/15 8K re: 4Qtr fin'l results
Goldman Sachs GS:
3/11/15 8K re: revised '15 Capital Plan
3/9/15 8K re: retirement from Board of Claes Dahlback
2/23/15 10K & 1/16/15 8K re: FY ended 12/31/15
2/8/15 8K re: issuance of Floating Rate Notes
1/23/15 8K re: issuance of notes
1/16/15 8K re: 4Qtr fin'l results
Home Depot HD:
2/24/15 8K re: FY & Qtr ended 2/1/15
1/16/15 8K re: replacement of Chairman of Board Francis S. Blake with Craig A. Menear
Intel INTC:
3/12/15 8K re: 1Qtr guidance
2/13/15 10K & 1/15/15 8K re: FY ended 12/27/14
1/15/15 8K re: fin'l results of 4Qtr ended 12/27
IBM:
3/19/15 Def. Proxy 14A Stockholders Annual Mtg at 10 am 4/.28/15 at Statehouse Conv. Ctr., Little Rock, Ark & nomination of Alex Gorsky, CEO, Johnson & Johnson & Peter R. Voser to Board
2/24/15 10K & 1/20/15 8K re: FY ended 12/31/14
2/5/15 8K re: issuance of debt securities
1/30/15 8K re: compensation amounts for execs for 2014
1/21/15 & 1/20/15 8Ks re: 4Qtr ended 12/31/14 fin'l results
1/7/15 8K re: exec promotions and amendment to bylaws to increase Board to 14 & election of Peter R. Voser to Bd
JPMorgan Chase JPM:
3/20/15 8K & 3/6/15 8K re: redemption of Bear Stearn Notes
3/6/15 8K re: release of '15 Dodd-Frank Act Stress Test results
2/27/15 8K re: redemption of Capital securities
2/25/15 8K re: 2/24/15 Investor Day Conf.
2/24/15 10K for FY ended 12/31/14
2/17/15 8K re: redemption of notes
2/12/15 8K re: issuance of Preferred Shares
1/23/15 8K re: closing of note offering
Johnson & Johnson JNJ:
3/11/15 Def. 14A Proxy for Annual shareholder Mtg a 10:30 am on 4/23/15 at State Theatre, New Brunswick, NJ
3/2/15 8K re: sale of Cordis Business for $1.99 bil to Cardinal Health
2/24/15 10K for FY ended 12/28/14
1/20/15 8K re: 4Qtr ended 12/28/14 fin'l results
McDonald's MCD:
3/20/15 8K re: stock award to execs
3/9/15 8K re: Feb. global sales
3/3/15 8K & 2/3/15 8K re: election of Stephen Easterbrook as CEO
2/24/15 10K for FY ended 12/31/14
2/10/15 8K re: Global sales for Jan.
2/4/15 8K re: TRC mini-tender offer
1/23/15 8K re: 4Qtr ended 12/31/14 fin'l results
Merck MRK:
2/27/15 10K & 2/4/15 8K re: FY ended 12/31/14
2/10/15 8K re: issuance of Floating rate Notes
Microsoft MSFT:
2/12/15 8K re: issuance of notes
1/26/15 10Q & 1/26/15 8K re: fin'l results for qtr ended 12/31/14
Nike NKE:
3/19/15 8K for Qtr ended 2/28/15
2/12/15 8K re: election & retirement of VPs
1/7/15 10Q & 12/2214 8K re: results of qtr ended 11/30
Pfizer PFE:
3/12/15 Def. 14A Proxy re: 4/23/15 Annual Shareholder Mtg at Short Hills, NJ
2/27/15 10K & 1/27/15 8K re: FY ended 12/31/15
2/10/15 8K re: $5 bil share buyback program
2/6/15 8K re: purchase of Hospira, Inc.
11/6/14 10Q for quarter ended 9/28/14
11/6/14 10Q & 10/28/14 8K re: 3Qtr ended 9/28/14
Procter & Gamble PG:
2/19/15 8K re: Consumer analysts Group conf. on 2/19/15
2/10/15 8K re: appointment of ex-Home depot CEO Frank S. Blake to Board
1/27/15 10Q & 1/27/15 8K re: 2Qtr ended 12/31/14 fin'l results
1/13/15 8K re: quarterly div. of 0.6436 cents payable 2/17 to record holders as of close of business
3M MMM:
2/23/15 8K purchase of Polypore's separation Media business
2/12/15 10K & 1/27/15 8K re: FY ended 12/31/14
1/31/15 8K re: 4Qtr fin'l results
Travelers TRV:
2/12/15 10K re: FY ended 12/31/14
1/22/15 8K re: qtr ended 12/31/14 fin'l results
United Technologies UTX:
3/13/15 Def. 14A Proxy re: Annual Mtg of Shareholders on 3/2/15 2pm at PGA Nat'l Resort, Palm Beach Gardens, FL
3/1/13/15 8K re: repurchase of $2.6 bil of stock
2/5/15 10K for FY ended 12/31/15
3/12/15 8K re: reviewing possible spin-off of Sikorsky Aircraft Business
1/26/15 8K re: 4Qtr fin'l results
1/23/15 8K re: separation agreement for ex-CEO Louis Chenevert
1/15/15 8K re: departure of exec Alain M. Bellemare
UnitedHealth Group UNH:
3/6/15 8K re: Barclays Global Healthcare Conf on 3/10 in Miami
2/17/15 8K re: exec. comp. changes
2/10/15 10K re: FY ended 12/31/14
2/6/15 8K re: Leenik Global Healthcare Conf. on 2/11
1/21/15 8K re: 4Qtr fin'l results
Verizon Communications Inc. VZ:
3/12/15 8K & 2/26/15 8K & 2/25/15 8K 2/12/15 8K re: results of exchange offer
2/23/15 10K re: FY ended 12/31/14
2/18/15 8K re: EVP changes
2/5/15 8K re: election of Mark T. Bertolini to Board
2/5/15 8K re: sale of assets, purchase of wireless towers & $5 bil stock buybacks
1/30/15 8K re: results of bidding for AWS-3 spectrum licenses in FCC auction
1/22/15 & 1/16/15 8Ks re: 4Qtr fin'l results
1/14/15 8K re: retirement from Board of Robert W. Lane
Visa V:
2/27/15 8K & two 1/29/15 8Ks: re: amd. by-laws to allow 4 for 1 stock splits
2/2/15 8K re: exec. changes
1/29/15 10Q & 1/29/15 8K re: 1Qtr ended 2/31/14 fin'l results
1/29/15 8K, 1/21/15 Proxy & 1/14/15 Proxy re: amendment of Cert of Incorp. for stock split
1/28/15 8K re: dividend of 48 cents payable 3/3 for record holders on 2/13
WalMart WMT:
2/19/15 8K re: 4Q results
12/16/14 8K re: latest ruling re: class action lawsuit in Phil for underpaying employees - Braun/Hummel v. Walmart
NO MAS
No comments:
Post a Comment